Research Article

Safety Assessment of Zigbir®: A Polyherbal Formulation in Sprague-Dawley Rats

Table 7

Absolute organ weights (g; mean ± SD) in female rats after 90 days subchronic oral administration of Zigbir®.

OrganControl250 mg/kg500 mg/kg1000 mg/kgControl recovery1000 mg/kg recovery

Terminal body weight232.66 ± 11.33228.66 ± 14.67216.17 ± 10.90204.97 ± 6.75268.78 ± 20.25255.00 ± 12.83
Brain 1.843 ± 0.0751.909 ± 0.0791.805 ± 0.0761.719 ± 0.0751.837 ± 0.0601.824 ± 0.054
Liver6.940 ± 1.0608.049 ± 0.4787.062 ± 0.8986.111 ± 0.5318.379 ± 1.1377.635 ± 0.708
Kidneys1.610 ± 0.1471.745 ± 0.1991.541 ± 0.1331.459 ± 0.0991.536 ± 0.2181.615 ± 0.124
Adrenals 0.0666 ± 0.0160.0747 ± 0.0070.0676 ± 0.0070.0628 ± 0.010.0608 ± 0.0020.0712 ± 0.009
Ovaries0.0956 ± 0.020.1077 ± 0.0140.0942 ± 0.0170.0956 ± 0.0130.146 ± 0.0430.1488 ± 0.029
Heart0.764 ± 0.0590.797 ± 0.0390.750 ± 0.0910.736 ± 0.0790.828 ± 0.1280.833 ± 0.089
Spleen 0.754 ± 0.1630.802 ± 0.0960.935 ± 0.1950.725 ± 0.0991.010 ± 0.0630.868 ± 0.104
Lungs1.307 ± 0.1671.598 ± 0.4281.514 ± 0.4091.317 ± 0.1681.007 ± 0.1051.02 ± 0.149
Uterus0.545 ± 0.155
0.549 ± 0.132
0.563 ± 0.167
0.492 ± 0.088
0.478 ± 0.119
0.522 ± 0.049